🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A phase 1/2 study to assess the safety and efficacy of MB-102 in patients w...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2020-02-17
Trial ID
NCT04109482
Treatments Being Tested
This is an open-label phase 1 study to assess the safety, feasibility, phar...
Status
Active Not Recruiting
Location
University of Pennsylvania
Start Date
2025-07-18
Trial ID
NCT06973096
RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2013-05
Trial ID
NCT01869166
Treatments Being Tested
Multi-center, open-label, first in human Phase 1 study of the safety, toler...
Status
Terminated
Location
Mayo Clinic of Arizona
Start Date
2019-10-10
Trial ID
NCT04025216
Treatments Being Tested
This phase I trial studies the side effects and best dose of EGFR/IL13Rα2 p...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-05-26
Trial ID
NCT07544992
This is a clinical study to observe the maximum tolerated dose (MTD) and th...
Status
Unknown
Location
Geng Tian 13724395569 Tiangeng666@Aliyun.Com
Start Date
2018-05-22
Trial ID
NCT03542799
Treatments Being Tested
This is a clinical study to observe the maximum tolerated dose (MTD) and th...
Status
Unknown
Location
The Second People's Hospital of Shenzhen
Start Date
2017-06-15
Trial ID
NCT03152435
Treatments Being Tested
This is an open-label phase 1 study to assess the safety and feasibility of...
Status
Active Not Recruiting
Location
University of Pennsylvania
Start Date
2023-02-24
Trial ID
NCT05168423
Treatments Being Tested
This is an open-label, phase 1b study to evaluate different approaches for ...
Status
Active Not Recruiting
Location
University of Pennsylvania
Start Date
2025-12-03
Trial ID
NCT07209241
Treatments Being Tested